Cardiol Therapeutics (CRDL) Total Current Liabilities (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Total Current Liabilities came in at $5.2 million in Q1 2026, down 3.79% YoY from $5.4 million in Q1 2025, and up 28.15% on a QoQ basis from $4.1 million in Q4 2025.
Cardiol Therapeutics (CRDL) Total Current Liabilities (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Total Current Liabilities data on file, last reported at $5.2 million in Q1 2026.
- Quarterly Total Current Liabilities fell 3.79% year-over-year to $5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (down 3.79% YoY) and the FY2025 annual result came in at $4.1 million, down 19.19% from the prior year.
- Total Current Liabilities rose to $5.2 million in Q1 2026, from $4.1 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $8.9 million in Q2 2022 to a low of $2.4 million in Q3 2025.
- A 5-year average of $6.1 million and a median of $6.0 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 274.35% — and 2025, when it sank 53.11%.
- Tracing CRDL's Total Current Liabilities over 5 years: stood at $7.2 million in 2022, then slipped by 15.64% to $6.1 million in 2023, then slipped by 17.65% to $5.0 million in 2024, then retreated by 19.19% to $4.1 million in 2025, then climbed by 28.15% to $5.2 million in 2026.
- The last three Total Current Liabilities figures came in at $5.2 million (Q1 2026), $4.1 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.79 Bn |
| 10 | Cardiol Therapeutics | 215.50 Mn | 196.65 Mn | - | 3.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.20 Mn |
| Dec 31, 2025 | 4.06 Mn |
| Sep 30, 2025 | 2.39 Mn |
| Jun 30, 2025 | 5.79 Mn |
| Mar 31, 2025 | 5.40 Mn |
| Dec 31, 2024 | 5.02 Mn |
| Sep 30, 2024 | 5.10 Mn |
| Jun 30, 2024 | 7.90 Mn |
| Mar 31, 2024 | 8.10 Mn |
| Dec 31, 2023 | 6.09 Mn |
| Sep 30, 2023 | 5.99 Mn |
| Jun 30, 2023 | 6.27 Mn |
| Mar 31, 2023 | 5.27 Mn |
| Dec 31, 2022 | 7.22 Mn |
| Sep 30, 2022 | 7.40 Mn |
| Jun 30, 2022 | 8.91 Mn |
| Mar 31, 2022 | 8.02 Mn |
| Dec 31, 2021 | 9.18 Mn |
| Sep 30, 2021 | 2.04 Mn |
| Jun 30, 2021 | 2.38 Mn |